Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
SIGN UP
SIGN IN
ENTITY
OSE Immuno (OSE FP)
Watchlist
36
Analysis
Health Care
•
France
OSE Immunotherapeutics SA is a biotechnology company based in France, developing immunotherapy products against invasive/metastatic late-stage cancers.
more
Watchlist
All
Insights
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bullish
•
OSE Immuno
•
16 Feb 2023 19:38
•
Issuer-paid
OSE Immunotherapeutics - FDA support received for Tedopi Phase III trial
OSE has announced that it has received positive recommendations from its ‘type C’ meeting with the FDA for the planned confirmatory Phase III trial...
Edison Investment Research
Follow
284 Views
Share
bullish
•
OSE Immuno
•
22 Dec 2022 23:18
•
Issuer-paid
OSE Immunotherapeutics - Introducing its fifth clinical asset
OSE Immunotherapeutics has announced the first patient dosing in a new trial, marking the introduction of the company’s fifth asset to clinical...
Edison Investment Research
Follow
668 Views
Share
bullish
•
OSE Immuno
•
20 Dec 2022 17:41
•
Issuer-paid
OSE Immunotherapeutics - €10m funding secures runway to Q323
OSE Immunotherapeutics (OSE) has announced the receipt of €10m in financing from the European Investment Bank (EIB), which we estimate will secure...
Edison Investment Research
Follow
676 Views
Share
bullish
•
OSE Immuno
•
15 Dec 2022 18:24
•
Issuer-paid
OSE Immunotherapeutics - OSE-127 encouraging preclinical data in ALL
OSE Immunotherapeutics (OSE) has reported positive preclinical efficacy data for its novel monoclonal antibody therapy OSE-127 in B- and T-cell...
Edison Investment Research
Follow
684 Views
Share
bullish
•
OSE Immuno
•
03 Nov 2022 17:02
•
Issuer-paid
OSE Immunotherapeutics - OSE-127 Phase II study enrolment completed
OSE Immunotherapeutics (OSE) completed patient recruitment in its Phase IIa study (NCT04605978) investigating its monoclonal antibody therapy,...
Edison Investment Research
Follow
295 Views
Share
First
Previous
1
2
3
4
5
6
Next
Last
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.34.5
x